Armand Butera

Previous contrasting studies found that omalizumab was less effective in reducing exacerbations in obese patients.

A total of 45 studies were selected for the systematic review, with non-White patients being underrepresented across them all.

Dr. Greenberg urges the ACIP to update their vaccine guidelines for patients 65 years and older to recommend high-dose flu vaccines.

The FDA began conducting research to support the development of bioequivalence recommendations for cyclosporine ophthalmic emulsion in 2012.

Investigators added that the meta-analysis contributed to the comparative effectiveness literature for AGA therapies regarding the compared interventions.

Investigators observed significant increases in the rate of encounters with children and adolescents with autism spectrum disorder, as well as those with anxiety and depression.

Investigators noted that clinically relevant risks could not be excluded with certainty despite not seeing a statistically significant increase in corresponding risks for more rare and severe thrombotic outcomes.

New data from the NAVIGATOR study found that tezepelumab was associated with fewer asthma exacerbations throughout all seasons of the year compared to placebo.

Dr. Shrine and colleagues conducted the largest genome-wide association study of coexisting asthma and COPD to date in a 2-stage design incorporating a total of 13 studies.

Dr. Bagel details newer topical therapies such as tapinarof and roflumilast, and speaks to how greater access to these therapies is needed among psoriasis patients.

Though continuous positive airway pressure and high-flow nasal oxygen have both been recommended for acute hypoxemic respiratory failure in patients infected with the COVID-19 virus, the effectiveness and safety of these strategies were uncertain.

Prior studies have predominantly considered the associations of respiratory allergy and skin allergy in patients with ADHD, with inconsistent data on food allergy.

Despite the prevalence of pulmonary exacerbations in patients with cystic fibrosis, there is no standardized definition to diagnose these events in affected patients.

Dr. Swamy speaks of the history of burnout that preceded the pandemic, and how physicians are struggling with emotional, mental, and physical trauma from COVID-19.

Despite being the fastest growing racial group in the United States, Asian Americans have remained underrepresented in health disparities research.

Significant associations between insomnia and race, sex, and psychiatric history were also observed.

While reporting for race and ethnicity in US studies had increased from 59.8% to 71.9%, the proportion of articles including at least 20% non-White representation remained unchanged.

Investigators say that reducing COVID-19 hospitalizations among these groups will require partnerships among homeless services, correctional facilities and agencies, health care professionals, and public health agencies.

Take a Break was a 3-week interactive experience that involved motivational text messages, challenge quizzes, brief goal setting and more.

The institute will assemble and support a diverse, multidisciplinary team of scientists and researchers to lead the charge breakthroughs in airway science.

Preconception paternal smoking was also not associated with birth weight or paternal BMI.

Despite the assumption of vaccine hesitancy among Black people in the US, the present study found rapid reductions in COVID-19 vaccine hesitancy among Black individuals in the US.

The therapeutic met all secondary endpoints measured at 18 months in patients with hATTR amyloidosis with polyneuropathy, which included statistically significant improvements in neuropathy, and quality of life.

After its approval by the FDA, no new safety findings were reported on weekly dosing of the biologic.

Patients with asthma were at increased risk of hospitalization and ICU admission or death, prompting investigators to suggest these patients be considered a priority group for booster COVID-19 vaccines.

Dr. Ivy speaks on promising new therapies and training for sickle cell management during the first blood shortage in the United States in 10 years.

Investigators note that validation of these biomarkers would require multi-center and independent validation of the current findings.

There are currently no approved systemic treatments for prurigo nodularis, but patients treated with dupilumab experienced significantly greater improvements in measures of overall health-related quality of life, skin pain, and symptoms of anxiety and depression.